Variable | Univariable analyses | Multivariable analyses | ||
---|---|---|---|---|
Hazard ratio (95% confidence interval) | p value | Hazard ratio (95% confidence interval) | p value | |
Age at perforation (referent: incremental increasing age by year) | 1.01 (0.99–1.03) | 0.18 | 0.99 (0.99–1.03) | 0.37 |
Gender (referent: male) | 1.01 (0.62–1.62) | 0.98 | 1.06 (0.64–1.76) | 0.80 |
Corticosteroids (referent: no corticosteroids) | 1.59 (0.94–2.67) | 0.09 | 1.75 (1.02–2.99) | 0.04 |
Time since last bevacizumab dose (referent: incremental time by weeks) | 0.99 (0.99–.00) | 0.82 | 1.00 (0.99–1.00) | 0.37 |
Surgery (referent: no surgery) | 0.49 (0.31–0.78) | 0.003 | 0.47 (0.29–0.74) | 0.002 |